中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
金属研究所 [2]
科技战略咨询研究院 [1]
动物研究所 [1]
采集方式
OAI收割 [4]
内容类型
期刊论文 [4]
发表日期
2021 [1]
2019 [1]
2017 [2]
学科主题
筛选
浏览/检索结果:
共4条,第1-4条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
提交时间升序
提交时间降序
作者升序
作者降序
发表日期升序
发表日期降序
Productivity assessment of the real estate industry in China: a DEA-Malmquist index
期刊论文
OAI收割
Engineering, Construction and Architectural Management, 2021, 期号: 0, 页码: 1-28
作者:
Liu Xiaoxiao
;
Liu Huihui
;
Yang Guoliang
;
Pan Jiaofeng
  |  
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2022/03/01
A non-enzymatic photoelectrochemical glucose sensor based on BiVO4 electrode under visible light
期刊论文
OAI收割
Sensors and Actuators B, 2019, 卷号: 291, 页码: 34-41
作者:
Shan Wang
;
Shaoping Li
;
Wenwen Wang
;
Mengting Zhao
;
Jiaofeng Liu
  |  
收藏
  |  
浏览/下载:20/0
  |  
提交时间:2020/11/17
Design, Synthesis and Biological Activities of N-(Furan-2-ylmethyl)-1H-indole-3-carboxamide Derivatives as Epidemal Growth Factor Receptor Inhibitors and Anticancer Agents
期刊论文
OAI收割
CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 2017, 卷号: 33, 期号: 3, 页码: 365-372
作者:
Zhang Lan
;
Deng Xinshan
;
Wu Jiaofeng
;
Meng Guangpeng
;
Liu Congchong
  |  
收藏
  |  
浏览/下载:57/0
  |  
提交时间:2021/02/02
MOLECULAR TARGETED DRUGS
TYROSINE KINASE
CANCER-CELLS
EGFR
RESISTANCE
POTENT
DISCOVERY
NSCLC
Anticancer activity
Epidemal growth factor receptor(EGFR) inhibitor
N-( Furan-2-ylmethyl)-1H-indole3-carboxamide derivative
Design, Synthesis and Biological Activities of N-(Furan-2-ylmethyl)-1H-indole-3-carboxamide Derivatives as Epidemal Growth Factor Receptor Inhibitors and Anticancer Agents
期刊论文
OAI收割
CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 2017, 卷号: 33, 期号: 3, 页码: 365-372
作者:
Zhang Lan
;
Deng Xinshan
;
Wu Jiaofeng
;
Meng Guangpeng
;
Liu Congchong
  |  
收藏
  |  
浏览/下载:58/0
  |  
提交时间:2021/02/02
MOLECULAR TARGETED DRUGS
TYROSINE KINASE
CANCER-CELLS
EGFR
RESISTANCE
POTENT
DISCOVERY
NSCLC
Anticancer activity
Epidemal growth factor receptor(EGFR) inhibitor
N-( Furan-2-ylmethyl)-1H-indole3-carboxamide derivative